Meilleur Acces aux Soins de Sante

MASS (Meilleur Accès aux Soins de Santé), also known as Better Access to Healthcare (BAH), is a specialized clinical research organization and site network based in Quebec, Canada. Founded in 2003, the company provides comprehensive clinical trial services, focusing on Phase II through Phase IV studies for the global pharmaceutical and biotechnology industries. MASS operates an integrated network of private medical clinics, facilitating efficient patient recruitment and high-quality data collection across various therapeutic fields such as cardiology, endocrinology, and respiratory health. By bridging the gap between clinical research and private medical practice, MASS accelerates the development of new therapies while ensuring strict adherence to international regulatory standards. The organization is recognized for its ability to rapidly enroll patients through its established relationships with primary care physicians and specialists in the Quebec region.